Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Distribution The mean volume of distribution (SD) of tesamorelin following a single subcutaneous administration of the 1.28 mg dose of EGRIFTA WR (11.6 mg/vial formulation) was 4.8 1.9 L/kg in healthy subjects
This creates a buffer layer that slightly dilutes the active ingredient concentration reaching your skin while maintaining hydration
Research focuses on effects of increased endogenous GH release without administering exogenous hormones
GHK-Cu topical: 1 %3 % for skin, 0.5 % for scalp AHK-Cu topical: 0.05 %0.1 % is standard in most hair serums - note this is much lower than GHK-Cu percentages Injectable AHK-Cu: less well characterised
This is more concentrated, meaning smaller injection volumes but more precise measuring required
Liver disease : liver enzyme monitoring is recommended in community use, and a baseline ALT/AST check is reasonable before starting
